NCT00104364View on ClinicalTrials.gov

A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Cancer

Interventions

DRUG

MK0731

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00104364 - A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED) | Biotech Hunter | Biotech Hunter